CIC
KRRO icon

Chilton Investment Company’s Korro Bio KRRO Stock Holding History

Chilton Investment Company’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-414
Closed -$730K – 160
2020
Q4 		$730K Hold
414
– – 0.02% 91
2020
Q3 		$398K Buy
414
+18
+5% +$19.3K 0.01% 119
2020
Q2 		$460K Buy
+396
New +$358K 0.02% 115

Other funds holding KRRO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Chilton Investment Company's KRRO Position: Q1 2021 in Review

Chilton Investment Company sold out of Korro Bio (KRRO) in Q1 2021, closing a stake of 414 shares — an estimated $730K sold.

Chilton Investment Company first reported a position in KRRO in Q2 2020 and held it in 3 quarters. The position peaked at $730K in Q4 2020. 115 funds tracked by Wall St. Rank hold KRRO as of Q1 2021.

  • Chilton Investment Company reported no remaining Korro Bio position as of Q1 2021 after selling out during the quarter.
  • Chilton Investment Company sold 414 Korro Bio shares in Q1 2021, an estimated $730K.
  • Chilton Investment Company first reported a position in Korro Bio in Q2 2020 and held it in 3 quarters.
  • Chilton Investment Company's Korro Bio position peaked at $730K in Q4 2020.
  • 115 funds tracked by Wall St. Rank held Korro Bio as of Q1 2021.

Based on Chilton Investment Company's 13F filing for Q1 2021, filed 11 May 2021.